Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Merck & Company | 2.68% | $51.56M | $301.74B | 42.13% | 80 Outperform | |
| AbbVie | 2.53% | $48.83M | $411.55B | 15.90% | 66 Neutral | |
| T Mobile US | 2.46% | $47.48M | $241.98B | -19.02% | 76 Outperform | |
| Johnson & Johnson | 2.23% | $43.05M | $586.40B | 55.16% | 78 Outperform | |
| Procter & Gamble | 2.11% | $40.67M | $370.79B | -5.78% | 69 Neutral | |
| Bristol-Myers Squibb | 1.97% | $37.88M | $122.90B | 8.64% | 78 Outperform | |
| Comcast | 1.86% | $35.78M | $113.51B | -13.38% | 74 Outperform | |
| Cisco Systems | 1.80% | $34.73M | $303.64B | 20.57% | 77 Outperform | |
| Amgen | 1.62% | $31.25M | $201.27B | 29.04% | 77 Outperform | |
| Lockheed Martin | 1.59% | $30.61M | $149.46B | 50.09% | 70 Outperform |